Pfizer AG - Comirnaty LP.8.1 10 μg, Injektionsdispersion
70400
01
Comirnaty LP.8.1 10 μg
Injektionsdispersion
J07BN01
06.08.2025
Composition
Suspension: COVID-19 mRNA LP.8.1 1 Dosis à 0.3 ml 10 µg pro dosi, ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas), 2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, saccharum, trometamolum, trometamoli hydrochloridum, aqua ad iniectabile, 1 ml corresp..
